Programmed Cell Death Ligand 1 Expression in a Case of Poorly Differentiated Lymphocyte-Rich Hepatocellular Carcinoma.
Clinical case reports(2021)
摘要
Our pathological study of a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.
更多查看译文
关键词
hepatocellular carcinoma,immune checkpoint inhibitors,lymphocyte-rich,lymphoepithelial,hepatocellular carcinoma,programmed cell death ligand 1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要